“The Abdominal Aortic Aneurysm market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period (2023-2032). Furthermore, launching various multiple- Abdominal Aortic Aneurysm pipeline products will significantly revolutionize the Abdominal Aortic Aneurysm market dynamics”
The Abdominal Aortic Aneurysm market report provides current treatment practices, Abdominal Aortic Aneurysm emerging drugs, market share of individual therapies, and current and forecasted 7MM Abdominal Aortic Aneurysm market size from 2019 to 2032. The report also covers current Abdominal Aortic Aneurysm treatment market practices/algorithms and unmet medical needs to curate the best opportunities and assess the market’s underlying potential.
Key Takeaways from the Abdominal Aortic Aneurysm Market Research Report
- The key driver for the surge in market size is the rise in number of Abdominal Aortic Aneurysm prevalent case in 7MM.
- According to the National Center for Chronic Disease Prevention and Health Promotion, Abdominal aortic aneurysms are more common in men.
- The leading companies working in the Abdominal Aortic Aneurysm market include TriVascular Inc., Endologix, Cordis Corporation, Carelon Research, Quintiles Inc., Lifetech Scientific (Shenzhen) Co. Ltd, Shape Memory Medical Inc., Bolton Medical, Boston Scientific Corporation, RSPR Pharma AB, ViTAA Medical Solutions, Philips Healthcare, Vascutek Ltd, Medtronic, AstraZeneca, Abbott Medical Devices, Nectero Medical Inc., and others.
- Promising Abdominal Aortic Aneurysm Pipeline Therapies in the various stages of development include IMPEDE-FX Embolization Plug, QUANTUM LP™ STENT GRAFT SYSTEM, Cordis AAA Bilateral Device, CRD007, Optilene® Mesh Elastic, Ticagrelor, PEVAR (ProGlide closure), AFX EVAR AAA Graft System, Aneufix ACP-T5, IQOS, Cigarette, and others.
- On February 2023, Endologix announced a study of Nellix System. The objective of this study is to assess the safety and effectiveness of the Endologix Nellix® System for the endovascular repair of infrarenal abdominal aortic aneurysms (AAA).
- On July 2023, Cordis Corporation announced a study of clinical trials for Endovascular abdominal aortic aneurysm repair. INSIGHT is a postmarket clinical follow-up study in the European Union. The purpose of the study is to continue to evaluate the safety and effectiveness/performance of INCRAFT in subjects with abdominal aortic aneurysms requiring endovascular repair in routine clinical practice. Approximately 150 subjects will be enrolled and followed through 5-years post procedure. Up to 25 sites in Europe may participate.
Discover more about therapies set to grab major Abdominal Aortic Aneurysm Market Share @ Abdominal Aortic Aneurysm Market Size
Abdominal Aortic Aneurysm Overview
Aneurysms that occur in the section of the aorta that runs through the abdomen (abdominal aorta) are called abdominal aortic aneurysms (Abdominal Aortic Aneurysm). The portion of the aorta that lies deep inside the abdomen, right in front of the spine, is called the abdominal aorta.
Abdominal Aortic Aneurysm Epidemiology Segmentation in the 7MM
- Total Abdominal Aortic Aneurysm Prevalent Population
- Abdominal Aortic Aneurysm Diagnosed Cases
- Abdominal Aortic Aneurysm Gender-Specific Prevalence
- Abdominal Aortic Aneurysm Treatable Cases
Download the report to understand which factors are driving Abdominal Aortic Aneurysm Epidemiology Trends @ Abdominal Aortic Aneurysm Epidemiological Insights
Abdominal Aortic Aneurysm Market Insights
Cardiovascular disease is widely recognized as the leading cause of death, a lesser-known fact is that aortic aneurysm (AA) is the 15th leading cause of death over the age of 65 years in the US. The golden standard of the treatments in Abdominal Aortic Aneurysm are invasive interventions either with open surgical repair (OS) or endovascular aneurysm repair (EVAR).
Abdominal Aortic Aneurysm Treatment Market
The concept of medical treatment is to prevent abdominal aortic aneurysm from rupture and avoid surgical treatment by preventing aneurysm enlargement or even reducing aneurysm size. Matrix metalloproteinases (MMP) are structurally related metalloendopeptidases that can degrade the extracellular matrix, and is thought to play important roles in Abdominal Aortic Aneurysm. There are many proposed pharmacological treatments, including β-blockers, angiotensin-converting enzyme inhibitor (ACE inhibitors), angiotensin-receptor blocker (ARB), statins, macrolides and, doxycycline, and an inhibitor of the MMP. Specific treatment is based on the age, overall health, medical history, and extent of the disease, signs and symptoms, tolerance of specific medications, procedures, or therapies.
To know more about Abdominal Aortic Aneurysm Treatment options, visit @ Abdominal Aortic Aneurysm Drugs
Abdominal Aortic Aneurysm Market Dynamics
The Abdominal Aortic Aneurysm market dynamics is anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, rise in the awareness of the disease, and incremental healthcare spending across the world. The current Abdominal Aortic Aneurysm pipeline is limited as only a few companies are working on Abdominal Aortic Aneurysm. It provides an opportunity for other companies to enter the market and grab a significant market share. A few companies are also involved in developing Medical devices for the Abdominal Aortic Aneurysm treatment.
Abdominal Aortic Aneurysm Market Emerging Therapy Assessment
The available therapeutics treatment options in Abdominal Aortic Aneurysm Landscape aim to reduce complications arising. Companies such as Merck Serono and AstraZeneca are involved in developing Abdominal Aortic Aneurysm therapies. Launch of Abdominal Aortic Aneurysm emerging therapies, such as Metformin Glucophage (Merck Serono) and Ticagrelor (AstraZeneca) is expected to impact the treatment scenario of AAA significantly. Expected launch of Merck Serono (Metformin Glucophage) and Ticagrelor (AstraZeneca)shall fuel the growth of the market during the forecast period (2019–2032).
- AFX® Endovascular ABDOMINAL AORTIC ANEURYSM System: Endologix LLC
The AFX® Endovascular ABDOMINAL AORTIC ANEURYSM System is an endovascular graft system intended to treat patients with ABDOMINAL AORTIC ANEURYSM. The device has a unique design in which the metal frame is on the inside of the fabric. It integrates anatomical fixation with an advanced delivery system and graft material technology. AFX® uses a low profile, precise delivery system and proprietary stent graft material (DuraPly™ ePTFE Graft Material) and provides reliable and durable ABDOMINAL AORTIC ANEURYSM repair. The AFX®2 bifurcated endograft system provides confident control for improved accessibility every step of the way.
- Abdominal Aortic Aneurysm Stent Graft System: Lifetech Scientific
The company’s ABDOMINAL AORTIC ANEURYSM Stent Graft System is indicated to treat patients with an infrarenal ABDOMINAL AORTIC ANEURYSMs. On September 30, 2018, Lifetech Scientific initiated its trial to evaluate the safety and efficacy of the ABDOMINAL AORTIC ANEURYSM Stent Graft System for the infrarenal ABDOMINAL AORTIC ANEURYSMs.
Products detail in the report…
- Fenestrated Altura FEVAR Stent Graft: Lombard Medical
Endovascular treatment of aortic diseases has improved in recent years. Fenestrated Endovascular Aortic Aneurysm Repair (FEVAR) is an almost new minimally invasive technique for repairing thoracoabdominal or complex ABDOMINAL AORTIC ANEURYSMs.
Learn more about the Abdominal Aortic Aneurysm Pipeline Therapies in clinical trials @ Abdominal Aortic Aneurysm Market Landscape
Scope of the Abdominal Aortic Aneurysm Market Report
- Coverage- 7MM
- Study Period- 2019-2032
- Abdominal Aortic Aneurysm Companies- TriVascular Inc.(NYSE: TRIV), Endologix (NYSE: ELGX), Cordis Corporation, Carelon Research, Quintiles Inc (NYSE: IQV)., Lifetech Scientific (Shenzhen) Co. Ltd, Shape Memory Medical Inc., Bolton Medical, Boston Scientific Corporation (NYSE: BSX), RSPR Pharma AB, ViTAA Medical Solutions, Philips Healthcare (NYSE: PHQ), Vascutek Ltd, Medtronic (NYSE: MDT), AstraZeneca (NYSE: AZN), Abbott Medical Devices (NYSE: ABT), Nectero Medical Inc., and others.
- Abdominal Aortic Aneurysm Pipeline Therapies- IMPEDE-FX Embolization Plug, QUANTUM LP™ STENT GRAFT SYSTEM, Cordis AAA Bilateral Device, CRD007, Optilene® Mesh Elastic, Ticagrelor, PEVAR (ProGlide closure), AFX EVAR AAA Graft System, Aneufix ACP-T5, IQOS, Cigarette, and others.
- Abdominal Aortic Aneurysm Market Dynamics: Abdominal Aortic Aneurysm Market Drivers and Barriers
- Abdominal Aortic Aneurysm Market Access and Reimbursement, Unmet Needs, Future Perspectives
Discover more about Abdominal Aortic Aneurysm Drugs in development @ Abdominal Aortic Aneurysm Ongoing Clinical Trials Analysis
Table of Content
- Key Insights
- Abdominal Aortic Aneurysm Market Report Introduction
- Abdominal Aortic Aneurysm Pharma Market Overview at a Glance
- Abdominal Aortic Aneurysm Disease Background and Overview
- Abdominal Aortic Aneurysm Treatment
- Abdominal Aortic Aneurysm: Regulatory Framework
- Abdominal Aortic Aneurysm: Reimbursement Scenario
- Abdominal Aortic Aneurysms: Marketed Products
- Abdominal Aortic Aneurysm: Emerging Devices
- Abdominal Aortic Aneurysm Epidemiology and Patient Population Analysis- 7MM
- Abdominal Aortic Aneurysm Pharma Market Analysis-7MM
- Abdominal Aortic Aneurysm Unmet Needs
- Abdominal Aortic Aneurysm Market Drivers
- Abdominal Aortic Aneurysm Market Barriers
- Abdominal Aortic Aneurysm SWOT Analysis
- DelveInsight Capabilities
- About DelveInsight
Top Selling Market Research Reports in 2023
Acute Pharyngitis Market | Bartonellosis Market | Concussions Market Size | Allergic Rhinoconjunctivitis Market | Atherectomy Devices Market | Heavy Metal Poisoning Markets | Nipah Virus Infection Market | Central Venous Catheters Market | Encephalitis Market | Vertigo Market | Blood Glucose Monitoring Systems Market | Bone Anchored Hearing Systems Market | Non Alcoholic Fatty Liver Disease Nafld Market | Bipolar Depression Market | Rett Syndrome Market | Central Serous Chorioretinopathy Market | Prosthetic Joint Infection Market | Calciphylaxis Market | Metastatic Bone Pain Market | Postsurgical Pain Market | Acute Ocular Pain Market | Bacteremia Market | Cardiopulmonary Bypass Equipment Market | Chronic Pain Associated With Painful Diabetic Neuropathy Market | Generalized Pustular Psoriasis Market | Parkinsons Disease Related Dementia Market | Polypoidal Choroidal Vasculopathy Market | Progressive Familial Intrahepatic Cholestasis Market | Waiha Market | Atypical Hemolytic Uremic Syndrome Ahus Market | Egfr Non-small Cell Lung Cancer Market | Reactive Arthritis Market | Central Retinal Venous Occulsion Market | Age Related Vision Dysfunction Market | Atopic Keratoconjunctivitis Akc Market | Hyperinsulinemic Hypoglycemia Market | Thyroid Eye Disease Market | Diffuse Cutaneous Systemic Sclerosis Market | Arteriovenous Fistula Market | Acrocallosal Syndrome Market | Treatment Resistant Depression Market | Catheter-related Bloodstream Infections Market | Absssi Market | Anaphylaxis Market | Pressure Ulcers Market Size
Read More about Consulting Services:
Biotech Consulting | Business Consulting Services | Consulting Services | Healthcare Business Development | Healthcare Consulting Services | Healthcare Strategy Consulting | Life Science Consulting | Life Science Consulting Firms
DelveInsight is a Business Consulting and Market research company, providing expert business solutions for the healthcare domain and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Healthcare Market Research Reports, Competitive Landscaping, and Mergers & Acquisitions.